UBS Group’s Magellan Health Services, Inc. MGLN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-91,000
Closed -$6.75M 8409
2019
Q2
$6.75M Buy
+91,000
New +$6.12M ﹤0.01% 2089

UBS Group's MGLN Position: Q1 2022 in Review

UBS Group sold out of Magellan Health Services, Inc. (MGLN) in Q1 2022, closing a stake of 365,865 shares — an estimated $34.8M sold.

UBS Group first reported a position in MGLN in Q4 2014 and held it in 29 quarters. The position peaked at $34.9M in Q3 2021. 0 funds tracked by Wall St. Rank hold MGLN as of Q1 2022.

  • UBS Group reported no remaining Magellan Health Services, Inc. position as of Q1 2022 after selling out during the quarter.
  • UBS Group sold 365,865 Magellan Health Services, Inc. shares in Q1 2022, an estimated $34.8M.
  • UBS Group first reported a position in Magellan Health Services, Inc. in Q4 2014 and held it in 29 quarters.
  • UBS Group's Magellan Health Services, Inc. position peaked at $34.9M in Q3 2021.
  • 0 funds tracked by Wall St. Rank held Magellan Health Services, Inc. as of Q1 2022.

Based on UBS Group's 13F filing for Q1 2022, filed 16 May 2022.